Skip to main content
Top
Published in: Pediatric Cardiology 4/2013

01-04-2013 | Review Article

Dexmedetomidine: Antiarrhythmic Effects in the Pediatric Cardiac Patient

Authors: Joseph D. Tobias, Constantinos Chrysostomou

Published in: Pediatric Cardiology | Issue 4/2013

Login to get access

Abstract

This report aims to provide a general description of the cardiovascular effects of dexmedetomidine, emphasizing its effects on conduction, and to give an evidence-based review of the literature regarding the use of dexmedetomidine to treat and prevent tachyarrhythmias in infants and children. A computerized bibliographic search of the literature on the use of dexmedetomidine to treat and prevent arrhythmias in infants and children was conducted. The cardiovascular effects of dexmedetomidine have been well studied in animal and adult human models. Growing experience, mostly in the pediatric population, has demonstrated the potential therapeutic applications of dexmedetomidine in the acute treatment of arrhythmias. Additionally, its use during cardiac surgery has been associated with a decreased incidence of postoperative ventricular and supraventricular tachyarrhythmias. Although dexmedetomidine is not currently approved by the Food and Drug Administration for the pediatric population, findings have shown it to be effective in various clinical scenarios for sedation. In addition, recent studies show that dexmedetomidine may have promising properties for the acute treatment and prevention of tachyarrhythmias.
Literature
1.
go back to reference Berkenbosch JW, Tobias JD (2003) Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 4:203–205PubMedCrossRef Berkenbosch JW, Tobias JD (2003) Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 4:203–205PubMedCrossRef
2.
go back to reference Bharati S, Pal A, Biswas C, Biswas R (2011) Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan 49:165–167PubMedCrossRef Bharati S, Pal A, Biswas C, Biswas R (2011) Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan 49:165–167PubMedCrossRef
3.
go back to reference Chrysostomou C, Beerman L, Shiderly D et al (2008) Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 107:1514–1522PubMedCrossRef Chrysostomou C, Beerman L, Shiderly D et al (2008) Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 107:1514–1522PubMedCrossRef
4.
go back to reference Chrysostomou C, Komarlu R, Lichtenstein S, Shiderly D, Arora G, Orr R, Wearden PD, Morell VO, Munoz R, Jooste EH (2010) Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 36:836–842PubMedCrossRef Chrysostomou C, Komarlu R, Lichtenstein S, Shiderly D, Arora G, Orr R, Wearden PD, Morell VO, Munoz R, Jooste EH (2010) Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 36:836–842PubMedCrossRef
5.
go back to reference Chrysostomou C, Sanchez-de-Toledo J, Wearden P et al (2011) Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Ann Thorac Surg 92:964–972PubMedCrossRef Chrysostomou C, Sanchez-de-Toledo J, Wearden P et al (2011) Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Ann Thorac Surg 92:964–972PubMedCrossRef
6.
go back to reference Chrysostomou C, Morell VO, Wearden P et al (2013) Dexmedetomidine: therapeutic use for the termination of reentrant tachycardia. Congenit Heart Dis 8(1):48–56 Chrysostomou C, Morell VO, Wearden P et al (2013) Dexmedetomidine: therapeutic use for the termination of reentrant tachycardia. Congenit Heart Dis 8(1):48–56
7.
go back to reference Delwadia S, Naguib A, Tobias J (2012) Dexmedetomidine controls supraventricular tachycardia following cardiac surgery in a child. World J Pediatr Congenit Heart Surg 3:406–409CrossRef Delwadia S, Naguib A, Tobias J (2012) Dexmedetomidine controls supraventricular tachycardia following cardiac surgery in a child. World J Pediatr Congenit Heart Surg 3:406–409CrossRef
8.
go back to reference Deutsch E, Tobias JD (2007) Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth 17:438–444PubMedCrossRef Deutsch E, Tobias JD (2007) Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth 17:438–444PubMedCrossRef
9.
go back to reference Finkel JC, Quezado ZMN (2007) Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth 19:290–292PubMedCrossRef Finkel JC, Quezado ZMN (2007) Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth 19:290–292PubMedCrossRef
10.
go back to reference Gerlach AT, Murphy CV (2009) Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 29:1492–1494PubMedCrossRef Gerlach AT, Murphy CV (2009) Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 29:1492–1494PubMedCrossRef
11.
go back to reference Hammer GB, Drover DR, Jackson E (2008) The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 106:79–83PubMedCrossRef Hammer GB, Drover DR, Jackson E (2008) The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 106:79–83PubMedCrossRef
12.
go back to reference Hayashi Y, Sumikawa K, Maze M, Yamatodani A, Kamibayashi T, Kuro I (1991) Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha two adrenoreceptors in halothane anesthetized dogs. Anesthesiology 75:113–117PubMedCrossRef Hayashi Y, Sumikawa K, Maze M, Yamatodani A, Kamibayashi T, Kuro I (1991) Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha two adrenoreceptors in halothane anesthetized dogs. Anesthesiology 75:113–117PubMedCrossRef
13.
go back to reference Herr DL, Sum-Ping ST, England M (2003) ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 17:576–584PubMedCrossRef Herr DL, Sum-Ping ST, England M (2003) ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 17:576–584PubMedCrossRef
14.
go back to reference Ingersoll-Weng E, Manecke GR, Thistlethwaite PA (2004) Dexmedetomidine and cardiac arrest. Anesthesiology 100:738–739PubMedCrossRef Ingersoll-Weng E, Manecke GR, Thistlethwaite PA (2004) Dexmedetomidine and cardiac arrest. Anesthesiology 100:738–739PubMedCrossRef
15.
go back to reference Jalonen J, Hynynen M, Kuitunen A, Heikkilä H, Perttilä J, Salmenperä M, Valtonen M, Aantaa R, Kallio A (1997) Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86:331–345PubMedCrossRef Jalonen J, Hynynen M, Kuitunen A, Heikkilä H, Perttilä J, Salmenperä M, Valtonen M, Aantaa R, Kallio A (1997) Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86:331–345PubMedCrossRef
16.
go back to reference Jooste EH, Muhly WT, Ibinson JW et al (2010) Acute hemodynamic changes following rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization. Anesth Analg 111:1490–1496PubMedCrossRef Jooste EH, Muhly WT, Ibinson JW et al (2010) Acute hemodynamic changes following rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization. Anesth Analg 111:1490–1496PubMedCrossRef
17.
go back to reference Kamibayashi T, Hayashi Y, Mammoto T, Yanatodani A, Sumikawa K, Yoshiya I (1995) Role of the vagus nerve in the antidysrhythmic effects of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83:992–999PubMedCrossRef Kamibayashi T, Hayashi Y, Mammoto T, Yanatodani A, Sumikawa K, Yoshiya I (1995) Role of the vagus nerve in the antidysrhythmic effects of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83:992–999PubMedCrossRef
18.
go back to reference LeRiger M, Naguib A, Galantowicz M, Tobias JD (2012) Dexmedetomidine controls junctional ectopic tachycardia during tetralogy of Fallot repair in an infant. Ann Card Anaesth 15:224–228PubMedCrossRef LeRiger M, Naguib A, Galantowicz M, Tobias JD (2012) Dexmedetomidine controls junctional ectopic tachycardia during tetralogy of Fallot repair in an infant. Ann Card Anaesth 15:224–228PubMedCrossRef
19.
go back to reference Mason KP, Zurakowski D, Zgleszewski SE et al (2008) High-dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 18:403–411PubMedCrossRef Mason KP, Zurakowski D, Zgleszewski SE et al (2008) High-dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 18:403–411PubMedCrossRef
20.
go back to reference Ohsugi E, Nagamine Y, Ohtsuka M (2011) The effect of dexmedetomidine in a child with intractable supraventricular tachyarrhythmias after total cavopulmonary connection. Masui 60:493–495PubMed Ohsugi E, Nagamine Y, Ohtsuka M (2011) The effect of dexmedetomidine in a child with intractable supraventricular tachyarrhythmias after total cavopulmonary connection. Masui 60:493–495PubMed
21.
go back to reference Parent B, Munoz R, Shiderly D, Chrysostomou C (2010) Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care 38:781–782PubMed Parent B, Munoz R, Shiderly D, Chrysostomou C (2010) Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care 38:781–782PubMed
22.
go back to reference Ruesch S, Levy JH (2002) Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg 95:316–318PubMed Ruesch S, Levy JH (2002) Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg 95:316–318PubMed
23.
go back to reference Salmenpera MT, Szlam F, Hug CC Jr (1993) Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology 78:813–820CrossRef Salmenpera MT, Szlam F, Hug CC Jr (1993) Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology 78:813–820CrossRef
24.
go back to reference Scheinin H, Jaakola ML, Sjövall S, Ali-Melkkilä T, Kaukinen S, Turunen J, Kanto J (1993) Intramuscular dexmedetomidine as premedication for general anesthesia: a comparative multicenter study. Anesthesiology 78:1065–1107PubMedCrossRef Scheinin H, Jaakola ML, Sjövall S, Ali-Melkkilä T, Kaukinen S, Turunen J, Kanto J (1993) Intramuscular dexmedetomidine as premedication for general anesthesia: a comparative multicenter study. Anesthesiology 78:1065–1107PubMedCrossRef
25.
go back to reference Shah A, Koneru J, Nicoara A et al (2007) Dexmedetomidine-related cardiac arrest in a patient with permanent pacemaker: a cautionary tale. PACE 30:1158–1160PubMedCrossRef Shah A, Koneru J, Nicoara A et al (2007) Dexmedetomidine-related cardiac arrest in a patient with permanent pacemaker: a cautionary tale. PACE 30:1158–1160PubMedCrossRef
26.
go back to reference Shepherd SM, Tejman-Yarden S, Khanna S et al (2011) Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med 39:187–189CrossRef Shepherd SM, Tejman-Yarden S, Khanna S et al (2011) Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med 39:187–189CrossRef
27.
go back to reference Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786PubMedCrossRef Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786PubMedCrossRef
28.
go back to reference Snapir A, Posti J, Kentala E et al (2006) Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 105:902–910PubMedCrossRef Snapir A, Posti J, Kentala E et al (2006) Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 105:902–910PubMedCrossRef
29.
go back to reference Tobias JD (2007) Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 8:115–131PubMedCrossRef Tobias JD (2007) Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 8:115–131PubMedCrossRef
30.
go back to reference Tobias JD (2008) Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 23:403–408PubMedCrossRef Tobias JD (2008) Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 23:403–408PubMedCrossRef
31.
go back to reference Tobias JD, Gupta P, Naguib A, Yates A (2011) Dexmedetomidine: applications in the pediatric patient with congenital heart disease. Pediatr Cardiol 32:1075–1087PubMedCrossRef Tobias JD, Gupta P, Naguib A, Yates A (2011) Dexmedetomidine: applications in the pediatric patient with congenital heart disease. Pediatr Cardiol 32:1075–1087PubMedCrossRef
32.
go back to reference Wang H, Han H, Zhang L et al (2001) Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 59:1029–1036PubMed Wang H, Han H, Zhang L et al (2001) Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 59:1029–1036PubMed
33.
go back to reference Zhang X, Schmidt U, Wain JC, Bigatello L (2010) Bradycardia leading to asystole during dexmedetomidine infusion in an 18-year-old double-lung transplant recipient. J Clin Anesth 22:45–49PubMedCrossRef Zhang X, Schmidt U, Wain JC, Bigatello L (2010) Bradycardia leading to asystole during dexmedetomidine infusion in an 18-year-old double-lung transplant recipient. J Clin Anesth 22:45–49PubMedCrossRef
Metadata
Title
Dexmedetomidine: Antiarrhythmic Effects in the Pediatric Cardiac Patient
Authors
Joseph D. Tobias
Constantinos Chrysostomou
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 4/2013
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-013-0659-7

Other articles of this Issue 4/2013

Pediatric Cardiology 4/2013 Go to the issue